Art. 2 Directive (EU) 2001/83

In forcesince 21 Jul 2011cited 76×
1.

This Directive shall apply to medicinal products for human use intended to be placed on the market in Member States and either prepared industrially or manufactured by a method involving an industrial process.

2.

In cases of doubt, where, taking into account all its characteristics, a product may fall within the definition of a ‘medicinal product’ and within the definition of a product covered by other Community legislation the provisions of this Directive shall apply.

3.

Notwithstanding paragraph 1 of this Article and Article 3(4), Title IV of this Directive shall apply to the manufacture of medicinal products intended only for export and to intermediate products, active substances and excipients.

4.

Paragraph 1 shall be without prejudice to Articles 52b and 85a.

The 10 that are cited most themselves, of 76.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (First Chamber) of 15 January 2009. Hecht-Pharma GmbH v Staatliches Gewerbeaufsichtsamt Lüneburg.Decisioninterprets

    This reference for a preliminary ruling concerns the interpretation of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, …

    15 Jan 2009 · 62007CJ0140

  • Judgment of the Court (First Chamber) of 15 November 2007. Commission of the European Communities v Federal Republic of Germany.Decision

    It is clear from Articles 2 and 6(1) of Directive 2001/83 that no industrially produced medicinal product may be placed on the market in a Member State unless a marketing authorisation has been issued by the competent authorities of that …

    15 Nov 2007 · 62005CJ0319

  • Judgment of the Court (First Chamber) of 9 June 2005. HLH Warenvertriebs GmbH (C-211/03) and Orthica BV (C-299/03 and C-316/03 to C-318/03) Decision

    … oktober 2005. Ved dette direktiv indsættes der således en ny artikel 2 i direktiv 2001/83, hvis stk. 2 hatfølgende ordlyd: »I tilfælde af tvivl om, hvorvidt et produkt ud fra en samlet bedømmelse af dets egenskaber kan være omfattet …

    9 Jun 2005 · 62003CJ0211

  • BGH, Urteil vom 24. Juni 2010 - I ZR 166/08Decision

    … allein die unmittelbare Wirkung des Erzeugnisses berücksichtigt, zu kurz greift, wird zudem durch die Bestimmung des Art. 2 Abs. 2 der Richtlinie 2001/83/EG in der durch die Richtlinie 2004/27/EG geänderten Fassung bestätigt. Danach …

    24 Jun 2010 · KORE315912010

  • Judgment of the Court (First Chamber) of 20 September 2007. Staat der Nederlanden v Antroposana, Patiëntenvereniging voor Antroposofische GeDecision

    Article 2 of Directive 2001/83 provides that the provisions of that directive are to apply to ‘industrially produced medicinal products for human use intended to be placed on the market in Member States’.

    20 Sep 2007 · 62006CJ0084

  • Judgment of the Court (Fourth Chamber), 3 October 2013. Laboratoires Lyocentre v Lääkealan turvallisuus- ja kehittämiskeskus and Sosiaali- jDecision

    This request for a preliminary ruling concerns the interpretation of Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ 1993 L 169, p. 1), as amended by Directive 2007/47/EC of the European Parliament and of the …

    3 Oct 2013 · 62012CJ0109

  • Judgment of the Court (Seventh Chamber) of 19 January 2023. L. GmbH and H. Ltd v Bundesrepublik Deutschland.Decisioninterprets

    These requests for a preliminary ruling concern the interpretation of Article 1(2)(a) of Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ 1993 L 169, p. 1), as amended by Directive 2007/47/EC of the European …

    19 Jan 2023 · 62021CJ0495

  • Regulation (EU) 2017/7454Law

    1. Без да се засяга член 2, параграф 2 от Директива 2001/83/ЕО, по надлежно обосновано искане на държава членка, Комисията, след …

  • Judgment of the Court (Third Chamber) of 16 July 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decisioninterprets

    These requests for a preliminary ruling concern the interpretation of Articles 2(1) and 3, points 1 and 2, of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal …

    16 Jul 2015 · 62013CJ0544